Preoperative Shock Indexes and Post-Spinal Hypotension in Cesarean Surgery
Predictive Performance of Preoperative Shock Index and Modified Shock Index for Hypotension Following Spinal Anesthesia in Elective Cesarean Surgery
1 other identifier
observational
300
1 country
1
Brief Summary
This prospective observational study aims to evaluate the predictive performance of preoperative Shock Index (SI) and Modified Shock Index (MSI) for hypotension following spinal anesthesia in elective cesarean surgery. Post-spinal hypotension is a common complication that can affect maternal and fetal outcomes, and early identification of at-risk patients is essential for effective perioperative management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
March 18, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2026
March 30, 2026
March 1, 2026
11 months
March 18, 2026
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Predictive performances of preoperative shock indexes for intraoperative hypotension
The ability of preoperative SI and MSI to predict intraoperative hypotension will be evaluated using receiver operating characteristic (ROC) analysis; area under the curve (AUC), sensitivity, specificity, and optimal cutoff values will be reported. SI is calculated as heart rate ÷ systolic blood pressure (HR/SBP); MSI is calculated as heart rate ÷ mean arterial pressure (HR/MAP). Hypotension is defined as a decrease of SBP to \<80% of baseline or SBP \<100 mmHg, or MAP \<80% of baseline or MAP \<65 mmHg.
From induction of spinal anesthesia until end of surgery
Secondary Outcomes (3)
Incidence of intraoperative hypotension
From induction of spinal anesthesia until end of surgery (intraoperative period)
Requirement for vasopressor treatment (ephedrine)
From induction of spinal anesthesia until end of surgery
Classification into hypotension vs. no-hypotension groups for comparison analyses
Intraoperative period
Study Arms (2)
Postspinal hypotension
All patients undergoing elective cesarean surgery under spinal anesthesia will be included in this study. Preoperative Shock Index (SI) and Modified Shock Index (MSI) will be calculated prior to anesthesia. Patients will be monitored during the surgery for hypotension. The patients who experience hypotension will be recorded as the post spinal hypotension group. The predictive performance of SI and MSI for post-spinal hypotension will be analyzed.
Post spinal non-hypotension
All patients undergoing elective cesarean surgery under spinal anesthesia will be included in this study. Preoperative Shock Index (SI) and Modified Shock Index (MSI) will be calculated prior to anesthesia. Patients will be monitored during the surgery for hypotension. The patients who do not experience hypotension will be recorded as the post spinal non-hypotension group. The predictive performance of SI and MSI for post-spinal hypotension will be analyzed
Eligibility Criteria
The study population will consist of pregnant women undergoing elective cesarean surgery under spinal anesthesia at Marmara University School of Medicine, Department of Anesthesiology.
You may qualify if:
- Patients over 18 years old
- ASA II-III patients undergoing elective cesarean section
You may not qualify if:
- ASA IV patients
- Patients with known neurologic or psychiatric disorders
- Patients with clinically significant cardiovascular, respiratory, hepatic, renal or metabolic disease
- Patients with alcohol or drug addiction
- Mentally disabled patients
- Patients with BMI\>30
- Patients who develop massive bleeding or coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University School of Medicine
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2026
First Posted
March 30, 2026
Study Start
October 15, 2025
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
August 30, 2026
Last Updated
March 30, 2026
Record last verified: 2026-03